Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 17, 2023

BUY
$220.43 - $278.69 $128,951 - $163,033
585 Added 36.91%
2,170 $604,000
Q3 2022

Nov 02, 2022

SELL
$120.36 - $205.88 $1,203 - $2,058
-10 Reduced 0.63%
1,585 $300,000
Q2 2022

Aug 12, 2022

BUY
$116.09 - $227.33 $184,583 - $361,454
1,590 Added 31800.0%
1,595 $198,000
Q1 2022

May 13, 2022

BUY
$187.51 - $283.98 $750 - $1,135
4 Added 400.0%
5 $1,000
Q4 2021

Feb 14, 2022

BUY
$238.08 - $288.0 $238 - $288
1 New
1 $0
Q4 2020

Feb 12, 2021

SELL
$174.98 - $272.83 $106,387 - $165,880
-608 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$185.27 - $238.73 $112,644 - $145,147
608 New
608 $118,000
Q2 2020

Aug 12, 2020

SELL
$153.32 - $191.72 $22,998 - $28,758
-150 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$115.84 - $160.31 $17,376 - $24,046
150 New
150 $22,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.09B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.